Hemophilia is a rare bleeding disorder characterized by low levels of proteins called “clotting factors.” Hemophilia is an inherited blood disorder in which your blood does not clot properly.

The NHS can now offer patients with a rare blood disorder a "transformative" new treatment after the UK's medicines watchdog gave its funding the green light. Around 200 people with haemophilia B ...

The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare bleeding disorder.

Sanofi’s Qfitlia (fitusiran) has been approved by the US Food and Drug Administration (FDA) as the first therapy to treat haemophilia A or B regardless ... haemostasis by lowering antithrombin, a ...